SCHEMBL7001422

SCHEMBL7001422

CCN(CC)CCNC(=O)CCCOc1cc[c]cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP3A4 P08684 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.50
HPGD P15428 4/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TAAR1 Q96RJ0 1/20 0.47
HTT P42858 1/20 0.45
GAA P10253 1/20 0.45
RECQL P46063 1/20 0.44
LMNA P02545 2/20 0.43
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7568865 0.87 SMN1; SMN2 (0.66) CYP1A2CYP2D6CYP3A4SMN1; SMN2HPGD
SCHEMBL7001340 0.85 SMN1; SMN2 (0.49) CYP1A2CYP2D6CYP3A4SMN1; SMN2HPGD
SCHEMBL7002893 0.85 CYP1A2 (0.73) CYP1A2CYP2D6CYP3A4SMN1; SMN2KMT2A
SCHEMBL7552633 0.83 SMN1; SMN2 (0.56) SMN1; SMN2HPGDMEN1KMT2ATAAR1
SCHEMBL7833557 0.79 GAA (0.48) CYP1A2CYP2D6CYP3A4SMN1; SMN2HPGD
SCHEMBL4467676 0.79 HPGD (0.53) SMN1; SMN2HPGDMEN1KMT2ATAAR1
SCHEMBL2181780 0.78 DRD2 (0.46) CYP1A2CYP2D6HTT
SCHEMBL7557779 0.78 CNR2 (0.57) SMN1; SMN2HPGDMEN1KMT2AALDH1A1
SCHEMBL19419 0.77 KDM4E (0.54) HRH3
SCHEMBL15904029 0.76 RECQL (0.72) SMN1; SMN2HPGDMEN1KMT2ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1165544-B1 SUBSTITUTED 1,4-DIHYDROINDENO[1,2-C]PYRAZOLES AS INHIBITORS OF TYROSINE KINASE KNOLL GMBH (DE) 2003-08-06 EP disclosed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
US-6297238-B1 3-ARYL PYRAZOLES WITH 4,5(3,4)-BICYCLIC RING FUSION WHICH ARE INHIBITORS OF PROTEIN KINASES PARTICULARLY TYROSINE KINASES AND SERINE/THREONINE KINASES BASF AKTIENGESELLSCHAFT (DE) 2001-10-02 US disclosed